Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
DR. Wang AS
AS
Active
Org 925273848
Tors Vei 16, 1464
Fjellhamar
General medical practice activities
·
NACE 8621
Est. 2020 · 5 years old
2 employees
Monitor
Share
Norway
/
Companies
/
General medical practice activities
/
DR. Wang AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
9M
7M
4M
2M
0M
2021: 3M
3M
2021
2022: 3M (0% vs 2021)
3M
0%
2022
2023: 5M (+67% vs 2022)
5M
+67%
2023
2024: 7M (+40% vs 2023)
7M
+40%
2024
2025: 7M (0% vs 2024)
7M
0%
2025
EBITDA
NOK millions
4M
3M
2M
1M
0M
2021: 1M
1M
2021
2022: 0M (-100% vs 2021)
0M
-100%
2022
2023: 2M
2M
2023
2024: 2M (0% vs 2023)
2M
0%
2024
2025: 3M (+50% vs 2024)
3M
+50%
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
2021
Revenue
6 990
6 788
5 284
2 764
2 559
Staff expenses
−1 879
−1 700
−1 086
−679
−196
EBITDA
2 591
2 378
1 861
490
1 083
Depreciation & amort.
−566
−455
−369
−290
−278
EBIT
2 026
1 923
1 491
200
805
Net financials
0
−12
−26
−14
−20
Profit before tax
2 026
1 911
1 466
185
785
Tax
448
421
322
41
173
Net profit
1 578
1 490
1 143
145
612
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
2021
Total assets
4 594
3 473
2 298
1 909
1 855
Equity
2 803
2 225
1 235
791
647
Long-term debt
62
70
284
883
959
Short-term debt
1 729
1 178
780
235
249
Total debt
1 791
1 248
1 064
1 118
1 208
Financial ratios
5-year trend
EBITDA margin
37.1%
This company
15.8%
Market median
This company
Market median
135% above market
2021
2025
Equity ratio
61.0%
This company
38.2%
Market median
This company
Market median
60% above market
2021
2025
Return on equity
56.3%
This company
18.4%
Market median
This company
Market median
206% above market
2021
2025
Net profit margin
22.6%
This company
8.1%
Market median
This company
Market median
179% above market
2021
2025
Asset turnover
1.52×
This company
1.12×
Market median
This company
Market median
36% above market
2021
2025
Debt / equity
0.64×
This company
0.62×
Market median
This company
Market median
3% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on DR. Wang AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
